Roche Holding AG Wins Reversal of $10.5 Million Accutane Verdict in New Jersey Case

Bloomberg -- Roche Holding AG won reversal of a $10.5 million verdict over its Accutane acne drug because a judge improperly barred the company from using evidence about the medication’s use, an appeals court ruled.
MORE ON THIS TOPIC